gms | German Medical Science

71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

21.06. - 24.06.2020

Functional outcome in patients with dural arteriovenous fistulae after surgical treatment

Funktionelles Outcome nach chirurgischer Therapie spinaler duraler arteriovenöser Fisteln

Meeting Abstract

  • presenting/speaker Isabel Hostettler - Klinikum rechts der Isar München, Neurochirurgische Klinik und Poliklinik, München, Deutschland
  • Lisa Hönikl - Klinikum rechts der Isar München, Neurochirurgische Klinik und Poliklinik, München, Deutschland
  • Bernhard Meyer - Klinikum rechts der Isar München, Neurochirurgische Klinik und Poliklinik, München, Deutschland
  • Maria Wostrack - Klinikum rechts der Isar München, Neurochirurgische Klinik und Poliklinik, München, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie. sine loco [digital], 21.-24.06.2020. Düsseldorf: German Medical Science GMS Publishing House; 2020. DocV159

doi: 10.3205/20dgnc157, urn:nbn:de:0183-20dgnc1573

Veröffentlicht: 26. Juni 2020

© 2020 Hostettler et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: Spinal dural arterio-venous fistulas (SDAVF) are rare vascular pathologies. The degree of symptom improvement after surgical treatment remains unclear. We evaluated surgically treated SDAVF patients for symptom improvement.

Methods: Retrospective inclusion of all patients treated surgically in our department for SDAVF consecutively between 2007 and 2019. We measured functional outcome using the McCormick Scale.

Results: We included a total of 27 patients. Mean age was 61.8years (standard deviation 8.4), 40.7% were female. The most frequent location was the thoracic spine in 15 (55.6%) followed by lumbar in 8 (29.6%), cervical in 3 (11.1%) and sacral spine in one patient (3.7%). The most common presenting symptom was progressive myelopathy in 24/27 patients (88.9%). Two patients (7.4%, both with foramen magnum SDAVF) presented with acute haemorrhage. Only in one patient was the SDAVF an incidental finding. In three patients (11.1%) SDAVF were embolised before surgery. In all patients the SDAVF was completely resected, however in 4 patients (14.8%) complete surgical resection required a second surgical interventions. Four patients (14.8%) deteriorated initially after surgery. On discharge, presenting symptoms had improved in 17 patients (63%), 9/27 patients (33.3%) had a McCormick score of 1. Follow-up was available in 19 patients (67.4%) with a median of 10.3 months (IQR 42.5, minimum 1.2, maximum 252). Seventeen patients (89.5%) continued to improve on follow-up. In total 22/27 patients (81.5%) improved.

Conclusion: Untreated SDAVF lead to progressive myelopathy which may result in considerable disability. Surgical disconnection and resection of the SDAVF provides a safe treatment option with relatively low perioperative morbidity and good chances for improvement or at least myelopathy progression prevention.